Mustang Bio Stock Analysis

Mustang Stock Analysis Notes

About 23.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 6.01. Mustang Bio had not issued any dividends in recent years. The entity had 1:15 split on the 4th of April 2023. Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. Mustang Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people. To find out more about Mustang Bio contact Manuel MD at 781 652 4500 or learn more at https://www.mustangbio.com.

Mustang Bio Investment Alerts

Mustang Bio Upcoming and Recent Events

Mustang Largest EPS Surprises

View All Earnings Estimates

Mustang Bio Thematic Classifications

Mustang Stock Institutional Investors

Note, although Mustang Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Mustang Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mustang Bio's market, we take the total number of its shares issued and multiply it by Mustang Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Mustang Profitablity

Management Efficiency

Mustang Bio has return on total asset (ROA) of (0.5756) % which means that it has lost $0.5756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.2244) %, meaning that it created substantial loss on money invested by shareholders. Mustang Bio's management efficiency ratios could be used to measure how well Mustang Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 27th of April 2024, Return On Tangible Assets is likely to grow to -2.76. In addition to that, Return On Capital Employed is likely to grow to -20.32. At this time, Mustang Bio's Net Tangible Assets are very stable compared to the past year. As of the 27th of April 2024, Non Current Assets Total is likely to grow to about 8.8 M, while Total Assets are likely to drop about 16.9 M.

Technical Drivers

As of the 27th of April, Mustang Bio secures the Risk Adjusted Performance of (0.17), standard deviation of 6.51, and Mean Deviation of 4.42. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mustang Bio, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for Mustang Bio, which can be compared to its peers in the industry. Please verify Mustang Bio risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Mustang Bio is priced some-what accurately, providing market reflects its recent price of 0.32 per share. As Mustang Bio appears to be a penny stock we also strongly suggest to check its jensen alpha numbers.

Mustang Bio Price Movement Analysis

Mustang Bio Insider Trading Activities

Mustang Bio Predictive Daily Indicators

Mustang Bio Forecast Models

Mustang Bio's time-series forecasting models are one of many Mustang Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mustang Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Mustang Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mustang shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Mustang Bio. By using and applying Mustang Stock analysis, traders can create a robust methodology for identifying Mustang entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Mustang analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Mustang analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Mustang Bio stock analysis indicators help investors evaluate how Mustang Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Mustang Bio shares will generate the highest return on investment. By understating and applying Mustang Bio stock analysis, traders can identify Mustang Bio position entry and exit signals to maximize returns.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.

Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.